| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 2.22e-06 | 38 | 49 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | calmodulin binding | 2.02e-05 | 230 | 49 | 6 | GO:0005516 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.00e-04 | 118 | 49 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.10e-04 | 9 | 49 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.10e-04 | 9 | 49 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | actin filament binding | 2.31e-04 | 227 | 49 | 5 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | 1.08e-03 | 479 | 49 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.45e-03 | 200 | 49 | 4 | GO:0008237 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 1.99e-03 | 27 | 49 | 2 | GO:0008066 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.75e-08 | 16 | 49 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 3.25e-07 | 25 | 49 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 5.23e-07 | 28 | 49 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 1.10e-05 | 59 | 49 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 5.73e-05 | 290 | 49 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | myofibril | 4.37e-04 | 273 | 49 | 5 | GO:0030016 | |
| Domain | Myosin_N | 4.71e-08 | 15 | 47 | 4 | IPR004009 | |
| Domain | Myosin_N | 4.71e-08 | 15 | 47 | 4 | PF02736 | |
| Domain | IQ | 5.14e-08 | 81 | 47 | 6 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 9.69e-08 | 90 | 47 | 6 | IPR000048 | |
| Domain | Myosin_tail_1 | 1.05e-07 | 18 | 47 | 4 | PF01576 | |
| Domain | Myosin_tail | 1.05e-07 | 18 | 47 | 4 | IPR002928 | |
| Domain | IQ | 1.18e-07 | 93 | 47 | 6 | PS50096 | |
| Domain | Myosin-like_IQ_dom | 1.33e-07 | 19 | 47 | 4 | IPR027401 | |
| Domain | - | 1.33e-07 | 19 | 47 | 4 | 4.10.270.10 | |
| Domain | IQ | 9.32e-07 | 71 | 47 | 5 | PF00612 | |
| Domain | MYOSIN_MOTOR | 2.44e-06 | 38 | 47 | 4 | PS51456 | |
| Domain | Myosin_head | 2.44e-06 | 38 | 47 | 4 | PF00063 | |
| Domain | Myosin_head_motor_dom | 2.44e-06 | 38 | 47 | 4 | IPR001609 | |
| Domain | MYSc | 2.44e-06 | 38 | 47 | 4 | SM00242 | |
| Domain | GPCR_3_mtglu_rcpt | 1.72e-04 | 8 | 47 | 2 | IPR000162 | |
| Domain | NCD3G | 4.75e-04 | 13 | 47 | 2 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 4.75e-04 | 13 | 47 | 2 | IPR011500 | |
| Domain | GPCR_3_CS | 5.53e-04 | 14 | 47 | 2 | IPR017979 | |
| Domain | Znf_C2H2 | 8.13e-04 | 805 | 47 | 8 | IPR007087 | |
| Domain | GPCR_3 | 1.26e-03 | 21 | 47 | 2 | IPR000337 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 1.39e-03 | 22 | 47 | 2 | PS50259 | |
| Domain | 7tm_3 | 1.39e-03 | 22 | 47 | 2 | PF00003 | |
| Domain | GPCR_3_C | 1.39e-03 | 22 | 47 | 2 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 1.39e-03 | 22 | 47 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 1.39e-03 | 22 | 47 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 1.39e-03 | 22 | 47 | 2 | PS00979 | |
| Domain | SAM | 1.41e-03 | 88 | 47 | 3 | SM00454 | |
| Domain | SAM_DOMAIN | 1.76e-03 | 95 | 47 | 3 | PS50105 | |
| Domain | SAM | 1.87e-03 | 97 | 47 | 3 | IPR001660 | |
| Domain | - | 2.40e-03 | 106 | 47 | 3 | 1.10.150.50 | |
| Domain | SAM/pointed | 3.18e-03 | 117 | 47 | 3 | IPR013761 | |
| Domain | GPS | 3.70e-03 | 36 | 47 | 2 | PS50221 | |
| Domain | GPS | 3.90e-03 | 37 | 47 | 2 | IPR000203 | |
| Domain | ANF_receptor | 3.90e-03 | 37 | 47 | 2 | PF01094 | |
| Domain | ANF_lig-bd_rcpt | 3.90e-03 | 37 | 47 | 2 | IPR001828 | |
| Domain | Peripla_BP_I | 4.33e-03 | 39 | 47 | 2 | IPR028082 | |
| Domain | zf-C2H2 | 7.51e-03 | 693 | 47 | 6 | PF00096 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 4.02e-05 | 70 | 39 | 4 | M12294 | |
| Pubmed | 3.48e-12 | 4 | 49 | 4 | 10388558 | ||
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 5.20e-11 | 6 | 49 | 4 | 10077619 | |
| Pubmed | 1.21e-10 | 7 | 49 | 4 | 35210422 | ||
| Pubmed | 1.14e-09 | 11 | 49 | 4 | 18310078 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 2.63e-09 | 3 | 49 | 3 | 26059207 | |
| Pubmed | 1.05e-08 | 4 | 49 | 3 | 11023856 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.05e-08 | 4 | 49 | 3 | 11029314 | |
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.05e-08 | 4 | 49 | 3 | 18417546 | |
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 2.62e-08 | 5 | 49 | 3 | 30737693 | |
| Pubmed | 2.62e-08 | 5 | 49 | 3 | 6196357 | ||
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 2.62e-08 | 5 | 49 | 3 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 2.62e-08 | 5 | 49 | 3 | 12919077 | |
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 1728586 | ||
| Pubmed | 5.24e-08 | 6 | 49 | 3 | 20417199 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 5.24e-08 | 6 | 49 | 3 | 17559643 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 5.24e-08 | 6 | 49 | 3 | 10588881 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 9.16e-08 | 7 | 49 | 3 | 29758057 | |
| Pubmed | 9.16e-08 | 7 | 49 | 3 | 16819597 | ||
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 26993635 | ||
| Pubmed | 1.46e-07 | 8 | 49 | 3 | 33667029 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.46e-07 | 8 | 49 | 3 | 14667415 | |
| Pubmed | 2.19e-07 | 9 | 49 | 3 | 31960486 | ||
| Pubmed | Developmental origin and morphogenesis of the diaphragm, an essential mammalian muscle. | 3.13e-07 | 10 | 49 | 3 | 29679560 | |
| Pubmed | Extracellular matrix protein composition dynamically changes during murine forelimb development. | 4.30e-07 | 11 | 49 | 3 | 38303699 | |
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 4.30e-07 | 11 | 49 | 3 | 29168801 | |
| Pubmed | 4.30e-07 | 11 | 49 | 3 | 8136524 | ||
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 4.30e-07 | 11 | 49 | 3 | 16024798 | |
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 7.44e-07 | 13 | 49 | 3 | 8404542 | |
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 24938781 | ||
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 27184118 | ||
| Pubmed | 9.46e-07 | 14 | 49 | 3 | 33742095 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 1.18e-06 | 15 | 49 | 3 | 24852826 | |
| Pubmed | 1.45e-06 | 16 | 49 | 3 | 16494860 | ||
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 1.45e-06 | 16 | 49 | 3 | 19922871 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 22940113 | ||
| Pubmed | IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism. | 1.76e-06 | 17 | 49 | 3 | 22351927 | |
| Pubmed | Myosin heavy chains IIa and IId are functionally distinct in the mouse. | 1.94e-06 | 2 | 49 | 2 | 9585413 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16575183 | ||
| Pubmed | Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. | 1.94e-06 | 2 | 49 | 2 | 7545970 | |
| Pubmed | Growth and muscle defects in mice lacking adult myosin heavy chain genes. | 1.94e-06 | 2 | 49 | 2 | 9382868 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11150240 | ||
| Pubmed | Myosin heavy chain composition of the human genioglossus muscle. | 1.94e-06 | 2 | 49 | 2 | 22337492 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 21102503 | ||
| Pubmed | Dose-response curves for radiation-induced gene mutations in mouse oocytes and their interpretation. | 1.94e-06 | 2 | 49 | 2 | 522864 | |
| Pubmed | Different pathways regulate expression of the skeletal myosin heavy chain genes. | 1.94e-06 | 2 | 49 | 2 | 11551968 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 22835638 | ||
| Pubmed | Skeletal muscle adaptations in response to voluntary wheel running in myosin heavy chain null mice. | 1.94e-06 | 2 | 49 | 2 | 11744674 | |
| Pubmed | Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. | 2.11e-06 | 18 | 49 | 3 | 25753484 | |
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 35365601 | ||
| Pubmed | Embryo model completes gastrulation to neurulation and organogenesis. | 3.97e-06 | 22 | 49 | 3 | 36007540 | |
| Pubmed | 3.97e-06 | 22 | 49 | 3 | 24301466 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 36515178 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 5.83e-06 | 3 | 49 | 2 | 1371481 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 8145163 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 25567808 | ||
| Pubmed | Epigenome-wide association data implicates DNA methylation-mediated genetic risk in psoriasis. | 5.83e-06 | 3 | 49 | 2 | 27980695 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 23339872 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 3904738 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21470888 | ||
| Pubmed | Specific isomyosin proportions in hyperexcitable and physiologically denervated mouse muscle. | 5.83e-06 | 3 | 49 | 2 | 15013776 | |
| Pubmed | 1.15e-05 | 31 | 49 | 3 | 31712428 | ||
| Pubmed | 1.15e-05 | 31 | 49 | 3 | 30081710 | ||
| Pubmed | 1.15e-05 | 31 | 49 | 3 | 21985497 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 22371395 | ||
| Pubmed | Identification of myosin II as a binding protein to the PH domain of protein kinase B. | 1.16e-05 | 4 | 49 | 2 | 10082674 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 20357587 | ||
| Pubmed | Control of muscle formation by the fusogenic micropeptide myomixer. | 1.16e-05 | 4 | 49 | 2 | 28386024 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 22474390 | ||
| Pubmed | Deficiency of Myo18B in mice results in embryonic lethality with cardiac myofibrillar aberrations. | 1.16e-05 | 4 | 49 | 2 | 18761673 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 1985022 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 12547197 | ||
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 1.39e-05 | 33 | 49 | 3 | 32094117 | |
| Pubmed | Mutations in a new scaffold protein Sans cause deafness in Jackson shaker mice. | 1.94e-05 | 5 | 49 | 2 | 12588793 | |
| Pubmed | Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice. | 1.94e-05 | 5 | 49 | 2 | 29653945 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 17928287 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 9119393 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 15142832 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 6879174 | ||
| Pubmed | Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. | 1.94e-05 | 5 | 49 | 2 | 17584907 | |
| Pubmed | 2.32e-05 | 39 | 49 | 3 | 38690566 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 19913010 | ||
| Pubmed | Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. | 2.91e-05 | 6 | 49 | 2 | 8824806 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 28806758 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 30044719 | ||
| Pubmed | NANOG initiates epiblast fate through the coordination of pluripotency genes expression. | 3.82e-05 | 46 | 49 | 3 | 35729116 | |
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 3.82e-05 | 46 | 49 | 3 | 28827394 | |
| Pubmed | Truncation of the catalytic domain of the cylindromatosis tumor suppressor impairs lung maturation. | 4.07e-05 | 7 | 49 | 2 | 19412431 | |
| Pubmed | Hox11-expressing interstitial cells contribute to adult skeletal muscle at homeostasis. | 4.07e-05 | 7 | 49 | 2 | 36815629 | |
| Pubmed | The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion. | 4.07e-05 | 7 | 49 | 2 | 26586200 | |
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 4.07e-05 | 7 | 49 | 2 | 20131355 | |
| Pubmed | Myomaker is a membrane activator of myoblast fusion and muscle formation. | 4.07e-05 | 7 | 49 | 2 | 23868259 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 3864153 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 36200826 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 25980463 | ||
| Pubmed | Pituitary phenotypes of mice lacking the notch signalling ligand delta-like 1 homologue. | 5.42e-05 | 8 | 49 | 2 | 23279263 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 28467822 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 28389228 | ||
| Pubmed | Lipid-anchored proteasomes control membrane protein homeostasis. | 5.42e-05 | 8 | 49 | 2 | 38019907 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 24727670 | ||
| Pubmed | BRAF activates PAX3 to control muscle precursor cell migration during forelimb muscle development. | 6.96e-05 | 9 | 49 | 2 | 27906130 | |
| Interaction | RSPH6A interactions | 1.05e-06 | 34 | 46 | 4 | int:RSPH6A | |
| Interaction | TSPAN33 interactions | 1.45e-05 | 65 | 46 | 4 | int:TSPAN33 | |
| Interaction | PRKAG2 interactions | 1.74e-05 | 68 | 46 | 4 | int:PRKAG2 | |
| Interaction | SBDS interactions | 5.62e-05 | 181 | 46 | 5 | int:SBDS | |
| Interaction | ATG101 interactions | 6.23e-05 | 94 | 46 | 4 | int:ATG101 | |
| Interaction | ASAH2 interactions | 7.60e-05 | 6 | 46 | 2 | int:ASAH2 | |
| Cytoband | 17p13.1 | 2.80e-04 | 118 | 49 | 3 | 17p13.1 | |
| Cytoband | 17q23.3 | 4.76e-04 | 30 | 49 | 2 | 17q23.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 5.14e-04 | 346 | 49 | 4 | chr17p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q11 | 8.25e-04 | 171 | 49 | 3 | chr17q11 | |
| Cytoband | 5q13.2 | 1.60e-03 | 55 | 49 | 2 | 5q13.2 | |
| Cytoband | 2q35 | 3.26e-03 | 79 | 49 | 2 | 2q35 | |
| Cytoband | 17q25.1 | 3.43e-03 | 81 | 49 | 2 | 17q25.1 | |
| Cytoband | 17q11.2 | 6.22e-03 | 110 | 49 | 2 | 17q11.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q23 | 7.35e-03 | 120 | 49 | 2 | chr17q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q35 | 8.45e-03 | 129 | 49 | 2 | chr2q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 9.09e-03 | 134 | 49 | 2 | chr7p22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q13 | 1.16e-02 | 152 | 49 | 2 | chr5q13 | |
| GeneFamily | Myosin heavy chains | 1.78e-08 | 15 | 36 | 4 | 1098 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.07e-04 | 8 | 36 | 2 | 281 | |
| GeneFamily | Sterile alpha motif domain containing | 7.08e-04 | 88 | 36 | 3 | 760 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.70e-03 | 718 | 36 | 6 | 28 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 6.43e-06 | 20 | 48 | 3 | M1123 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 7.49e-06 | 21 | 48 | 3 | MM1102 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 1.46e-05 | 440 | 48 | 7 | M39039 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_DN | 3.55e-05 | 101 | 48 | 4 | M1514 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | 1.88e-05 | 270 | 44 | 6 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-10 | 166 | 48 | 7 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-10 | 166 | 48 | 7 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | (6)_Endothelial-C_(Capillary_Aerocyte_)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.09e-08 | 193 | 48 | 6 | f7f2dc6aff02d096a282835094d26d12b3b73e61 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.28e-08 | 194 | 48 | 6 | e55dc30e200c9f576804acb642175eb4fa9146b5 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.30e-08 | 199 | 48 | 6 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | distal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.52e-08 | 200 | 48 | 6 | e12598a097dd9c4cbf9bb85bfa3057722ef73ad5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-07 | 162 | 48 | 5 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.60e-07 | 162 | 48 | 5 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-06 | 172 | 48 | 5 | 6f302ed795767a9636081dc64373f8f039ea16d2 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-06 | 172 | 48 | 5 | fd8097299fc05390b30afaa9e6c80b1f607c27aa | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-06 | 173 | 48 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-06 | 180 | 48 | 5 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-06 | 180 | 48 | 5 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.46e-06 | 77 | 48 | 4 | 7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5 | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.48e-06 | 181 | 48 | 5 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 184 | 48 | 5 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.65e-06 | 185 | 48 | 5 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-Aerocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.65e-06 | 185 | 48 | 5 | 7b3d30a54bec66ca6b0209c86448f4fff97ed75c | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic-endo_lymphatic_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 186 | 48 | 5 | f51c76b1c3c6c49e0ebc9a913d8413e0b6a04d80 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 186 | 48 | 5 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-lymphatic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.70e-06 | 186 | 48 | 5 | 86b218a400f9c64f92b050f00b49f09647b17437 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 186 | 48 | 5 | b80aaeebc03a318052076d2f02c123f5ddc5e73a | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.70e-06 | 186 | 48 | 5 | 8a8ed1502542d4895cba3fd5d534256206578716 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.83e-06 | 189 | 48 | 5 | b028466fcd36fdeceec752e55a24286a1cd62ae4 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-06 | 189 | 48 | 5 | 2e43428f1ef9683c6f8c9897d46aa7d34bf9047f | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.88e-06 | 190 | 48 | 5 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.88e-06 | 190 | 48 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | COVID-19-Heart-Mito_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-06 | 190 | 48 | 5 | ea74e0e38bcaba125b48c88331e9ba09228d3178 | |
| ToppCell | 10x5'v1-week_12-13-Endothelial-stroma-tip_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.93e-06 | 191 | 48 | 5 | cf1a67b7c0d5c0dc5d4d59faf9d9b1a3a1fb00e0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.98e-06 | 192 | 48 | 5 | c0e59e642b42c055cf73d029cf54d07d9b719359 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.03e-06 | 193 | 48 | 5 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial1_(12)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.03e-06 | 193 | 48 | 5 | d338a7c0585b69947c37f44aa0381619493e31ea | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.03e-06 | 193 | 48 | 5 | 643f992dbce639e7d147924d8b8f455fcebf215a | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.09e-06 | 194 | 48 | 5 | 9bd25ea57f2da27bd200d1a8bf797fec77d172c7 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 196 | 48 | 5 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.19e-06 | 196 | 48 | 5 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | PCW_13-14-Endothelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | 7286de29a34e13834cd6347c67a1443897fa4ade | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | b826dce5b3daa8eb3d4a530b9564de58d9ce3767 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature-endo_immature_venous_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | 81278e696d823744267d6315c4d42799c4ea0b2c | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | 9ed96085f0acce07bf2f8d4cc212cc50e613be0c | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.19e-06 | 196 | 48 | 5 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.19e-06 | 196 | 48 | 5 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-06 | 196 | 48 | 5 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.25e-06 | 197 | 48 | 5 | e567f91fa398fd306d025dcfe89bd50a60216537 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-06 | 197 | 48 | 5 | 412cb5f37df57121ddd1492021445479c7cbccbf | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.25e-06 | 197 | 48 | 5 | aedc1e3ed6b558bf2f7649919f43049f8348ab85 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.30e-06 | 198 | 48 | 5 | eac26ed95b4a4343a5dfe1fbecef9374e5947884 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.30e-06 | 198 | 48 | 5 | 5fe186d46c47ea1ca450cf67e8eb01c2c3f7f83c | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.30e-06 | 198 | 48 | 5 | 8fb624407abb9cb711d8d8a8665014cf6e39559a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.36e-06 | 199 | 48 | 5 | edb68a4f622a494f22fd7b25bc40ae0d58456cdb | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-06 | 199 | 48 | 5 | 45f9c03d2ed2d98d66086fb0251bd24e30c6f775 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.36e-06 | 199 | 48 | 5 | 448dd5a27d57627468c6b8347f1b6b1005aea004 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.36e-06 | 199 | 48 | 5 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 200 | 48 | 5 | d36236c7703b759309c8347f44900fc4bed377f0 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-4|TCGA-Thymus / Sample_Type by Project: Shred V9 | 6.06e-06 | 110 | 48 | 4 | 56e93e8d0d6232ab9090f685e5e4803ef79b2567 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.27e-06 | 119 | 48 | 4 | 8a3f0a3ed9f80d7b061162e9fa519bb09804a86c | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.27e-06 | 119 | 48 | 4 | 938da0fe90372709048bf4e5503cc1cbf8376b17 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Cdkn2b_(Cdkn2b)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.27e-06 | 119 | 48 | 4 | a3807e738d7ca8cf80aa4bd35e3ee4357b1dc00f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.00e-05 | 125 | 48 | 4 | d05556ea185c15815a4f8643f1c01185badbeece | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.21e-05 | 131 | 48 | 4 | 308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-05 | 136 | 48 | 4 | 82b1d6d839c0d0c68e0960549f688138479defcc | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 139 | 48 | 4 | 34398a6f21a1e670497655a7bb7f3cde9e117560 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.53e-05 | 139 | 48 | 4 | 450c4152c9fe4ec503271bb3cf93739918c59509 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_STALK|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.71e-05 | 143 | 48 | 4 | 35d3652680c4dddd293301595d813161c66e5673 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Ptgdr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.76e-05 | 144 | 48 | 4 | 71107275767a0728541a3695715c44874b3e5efc | |
| ToppCell | COVID-19-kidney-Mito-rich_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 145 | 48 | 4 | afed661aef990edb8e7012ab67ace56443520c9f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.90e-05 | 147 | 48 | 4 | 50e86860a94be103092c40e39a172eac92372f0d | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.28e-05 | 154 | 48 | 4 | b0735365de153d4586ca17896431d7bd9c7d8eac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 156 | 48 | 4 | f894fac4e44a23718b20ad80c9677bf4f2118002 | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.65e-05 | 160 | 48 | 4 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | COVID-19-kidney-Epithelial_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.65e-05 | 160 | 48 | 4 | 0d4880f85565d8c540c94a8f8109147b3029279a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.65e-05 | 160 | 48 | 4 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-05 | 164 | 48 | 4 | 3cd80e6275f0f9b5667912139d15ebf5e6b17f2f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-05 | 164 | 48 | 4 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 2.99e-05 | 165 | 48 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 3.14e-05 | 167 | 48 | 4 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 171 | 48 | 4 | 4e856441063e9825b6f87a1d3dd19c77dae4662c | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 3.52e-05 | 172 | 48 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-05 | 172 | 48 | 4 | c056d44e2e130ceccadfcdceb192a7f095d779c8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 173 | 48 | 4 | 0b79e2a4fd19d524c24b69a6b524ffc6affdabe5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 173 | 48 | 4 | a2c1ef3f4d7e9f68fc77ee7c42a4727bdea5da94 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 173 | 48 | 4 | 4830136f1f1976e00ac9af9062a531ac42533041 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.68e-05 | 174 | 48 | 4 | 3d4c05ea5719ca65e85d1f15198453034791087c | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | fa6eb451555766398996bbe8f555a3f4c0f3c108 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | 1f5b0fa58b2a7335667357af7e50e5242cd13d7d | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | ac3aee6ed49d1c421f33509e3ffc5cb17750a473 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.68e-05 | 174 | 48 | 4 | b1bcd5f4505d2ccef4183fcfbf1de81964b3f9e0 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-05 | 174 | 48 | 4 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.68e-05 | 174 | 48 | 4 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.76e-05 | 175 | 48 | 4 | 90302e8a44858ef3b2a165b88284d4788d591a99 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 176 | 48 | 4 | 1df7b6ce2519ad99bacbbaf1a8d5929e11513faa | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.94e-05 | 177 | 48 | 4 | 6248c0dcad302de61a66163ee84b3b79096150d7 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.02e-05 | 178 | 48 | 4 | 360d7a987f91d6d721487a921824057ec31a7332 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.02e-05 | 178 | 48 | 4 | 5f779a66aa42d1d8e8af17b4a08d5dcc733efd4c | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.02e-05 | 178 | 48 | 4 | a3f95f0002f408b5b6c57e28b297b5b2737e919c | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 179 | 48 | 4 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.11e-05 | 179 | 48 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.11e-05 | 179 | 48 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Nr2f2_(MGE-derived_cortical_interneurons--Martinotti_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.12e-05 | 62 | 48 | 3 | a20620a8869721ea62984c2022ee1b484b455824 | |
| Drug | NSC339663 | 1.03e-06 | 250 | 49 | 7 | CID000003892 | |
| Drug | fast white | 2.00e-06 | 42 | 49 | 4 | CID000024008 | |
| Drug | nifedipine | 2.67e-06 | 415 | 49 | 8 | CID000004485 | |
| Drug | formycin triphosphate | 4.39e-06 | 51 | 49 | 4 | CID000122274 | |
| Drug | purealin | 7.37e-06 | 58 | 49 | 4 | CID006419303 | |
| Drug | 3,4-dihydroxyphenylglycine | 1.21e-05 | 21 | 49 | 3 | CID000027915 | |
| Drug | clenbuterol | 1.34e-05 | 142 | 49 | 5 | CID000002783 | |
| Drug | SM-2 | 3.70e-05 | 87 | 49 | 4 | CID000486033 | |
| Drug | LY393675 | 4.52e-05 | 5 | 49 | 2 | CID005311262 | |
| Drug | 15 Z | 4.52e-05 | 5 | 49 | 2 | CID005322065 | |
| Drug | artocarpesin | 4.52e-05 | 5 | 49 | 2 | CID000399491 | |
| Drug | DMeOB | 4.52e-05 | 5 | 49 | 2 | CID002061047 | |
| Drug | tyrphostin B52 | 4.52e-05 | 5 | 49 | 2 | CID005328773 | |
| Drug | TG-3 | 4.88e-05 | 33 | 49 | 3 | CID000205489 | |
| Drug | quinonoid dihydro-(6H)-biopterin | 5.35e-05 | 34 | 49 | 3 | CID000000252 | |
| Drug | S-(-)-Etomoxir | 6.38e-05 | 100 | 49 | 4 | CID000060765 | |
| Drug | Tinidazole [19387-91-8]; Up 200; 16.2uM; HL60; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 2568_UP | |
| Drug | AC1MBZ3L | 6.77e-05 | 6 | 49 | 2 | CID002733524 | |
| Drug | MTEP | 6.77e-05 | 6 | 49 | 2 | CID009794218 | |
| Drug | anemonin | 6.77e-05 | 6 | 49 | 2 | CID000010496 | |
| Drug | SIB-1757 | 6.77e-05 | 6 | 49 | 2 | CID006304902 | |
| Drug | verapamil | 8.05e-05 | 490 | 49 | 7 | CID000002520 | |
| Drug | CDPPB | 9.46e-05 | 7 | 49 | 2 | CID011245456 | |
| Drug | NDMs | 9.46e-05 | 7 | 49 | 2 | CID000129833 | |
| Drug | norartocarpetin | 9.46e-05 | 7 | 49 | 2 | CID005481970 | |
| Drug | azetidine-2,4-dicarboxylic acid | 9.46e-05 | 7 | 49 | 2 | CID000005370 | |
| Drug | MCCG-I | 9.46e-05 | 7 | 49 | 2 | CID005311457 | |
| Drug | carbachol | 1.01e-04 | 688 | 49 | 8 | CID000002551 | |
| Drug | Dimercaprol | 1.01e-04 | 42 | 49 | 3 | ctd:D004112 | |
| Drug | isobutyramide | 1.01e-04 | 42 | 49 | 3 | CID000068424 | |
| Drug | blebbistatin | 1.14e-04 | 116 | 49 | 4 | CID003476986 | |
| Drug | B0683 | 1.17e-04 | 117 | 49 | 4 | CID006398969 | |
| Drug | cis-MCG-I | 1.26e-04 | 8 | 49 | 2 | CID003035584 | |
| Drug | calcitonin gene-related peptide (8-37) | 1.26e-04 | 8 | 49 | 2 | ctd:C058636 | |
| Drug | X1240 | 1.26e-04 | 8 | 49 | 2 | CID005321884 | |
| Drug | dieckol | 1.26e-04 | 8 | 49 | 2 | CID003008868 | |
| Drug | oxovanadium | 1.29e-04 | 120 | 49 | 4 | CID000024411 | |
| Drug | 2bq7 | 1.42e-04 | 123 | 49 | 4 | CID006540267 | |
| Drug | AC1NRCU6 | 1.62e-04 | 9 | 49 | 2 | CID005289186 | |
| Drug | AC1N21PP | 1.62e-04 | 9 | 49 | 2 | CID004014619 | |
| Drug | 1,3-cyclopentanedicarboxylic acid | 1.62e-04 | 9 | 49 | 2 | CID000107216 | |
| Drug | mM PEP | 1.62e-04 | 9 | 49 | 2 | CID005311462 | |
| Drug | thiourea | 1.66e-04 | 128 | 49 | 4 | CID002723790 | |
| Drug | AC1LADJ6 | 1.76e-04 | 130 | 49 | 4 | CID000486032 | |
| Drug | nobiletin | 1.92e-04 | 52 | 49 | 3 | CID000072344 | |
| Drug | K-Cl | 1.99e-04 | 567 | 49 | 7 | CID000004873 | |
| Drug | FA-Ala-arg | 2.02e-04 | 10 | 49 | 2 | CID006444034 | |
| Drug | Phosphatidylserine | 2.02e-04 | 10 | 49 | 2 | DB00144 | |
| Drug | NS-105 | 2.02e-04 | 10 | 49 | 2 | CID000198695 | |
| Drug | 3-methylquercetin | 2.03e-04 | 53 | 49 | 3 | ctd:C047368 | |
| Drug | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2.09e-04 | 400 | 49 | 6 | ctd:C085911 | |
| Drug | ethyl acetate | 2.15e-04 | 137 | 49 | 4 | CID000008857 | |
| Drug | AC1NRBPQ | 2.15e-04 | 137 | 49 | 4 | CID005288569 | |
| Drug | NSC9700 | 2.23e-04 | 578 | 49 | 7 | CID000005408 | |
| Drug | NSC226080 | 2.42e-04 | 782 | 49 | 8 | CID000005040 | |
| Drug | ketamine | 2.45e-04 | 262 | 49 | 5 | CID000003821 | |
| Drug | N-anisoyl-GABA | 2.46e-04 | 11 | 49 | 2 | CID000155723 | |
| Drug | cyclobutylene AP5 | 2.46e-04 | 11 | 49 | 2 | CID000126582 | |
| Drug | kuwanon C | 2.46e-04 | 11 | 49 | 2 | CID005481958 | |
| Drug | NSC625381 | 2.68e-04 | 145 | 49 | 4 | CID000002592 | |
| Drug | candesartan cilexetil | 2.68e-04 | 145 | 49 | 4 | CID000002540 | |
| Drug | forskolin from Coleus forskohlii | 2.72e-04 | 1013 | 49 | 9 | CID000003413 | |
| Drug | beta-ionone | 2.95e-04 | 12 | 49 | 2 | ctd:C008157 | |
| Drug | AMN082 | 2.95e-04 | 12 | 49 | 2 | CID001894360 | |
| Drug | AC1N9ZZC | 2.97e-04 | 149 | 49 | 4 | CID004369374 | |
| Drug | Spermine | 3.40e-04 | 63 | 49 | 3 | ctd:D013096 | |
| Drug | rhapontigenin | 3.49e-04 | 13 | 49 | 2 | CID005320954 | |
| Drug | AC1NSKBB | 3.49e-04 | 13 | 49 | 2 | CID005311256 | |
| Drug | Mspg | 3.49e-04 | 13 | 49 | 2 | CID003964410 | |
| Drug | MSOPPE | 3.49e-04 | 13 | 49 | 2 | CID005311463 | |
| Drug | 20(S)-Propanaxidiol | 3.49e-04 | 13 | 49 | 2 | CID005317623 | |
| Drug | homocysteic acid | 3.90e-04 | 66 | 49 | 3 | CID000092117 | |
| Drug | carvedilol | 3.98e-04 | 161 | 49 | 4 | CID000002585 | |
| Drug | 2-methyl-6-styrylpyridine | 4.06e-04 | 14 | 49 | 2 | CID000235382 | |
| Drug | sodium metasilicate nonahydrate | 4.06e-04 | 14 | 49 | 2 | CID000061495 | |
| Drug | MTPG | 4.06e-04 | 14 | 49 | 2 | CID005311456 | |
| Drug | 2-amino-4-phosphonobutyric acid | 4.06e-04 | 14 | 49 | 2 | ctd:C012729 | |
| Drug | AC1L197D | 4.07e-04 | 67 | 49 | 3 | CID000000425 | |
| Drug | AC1L1M7Y | 4.25e-04 | 68 | 49 | 3 | CID000057056 | |
| Drug | AM251 | 4.63e-04 | 70 | 49 | 3 | CID000002125 | |
| Drug | AC1MLTEL | 4.68e-04 | 15 | 49 | 2 | CID003250250 | |
| Drug | amentoflavone | 4.68e-04 | 15 | 49 | 2 | ctd:C011164 | |
| Drug | ifenprodil | 4.83e-04 | 71 | 49 | 3 | CID000003689 | |
| Drug | T2755 | 4.83e-04 | 71 | 49 | 3 | CID000005514 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.28e-09 | 10 | 48 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 3.02e-09 | 12 | 48 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 3.02e-09 | 12 | 48 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 4.36e-09 | 13 | 48 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 8.30e-09 | 15 | 48 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.14e-06 | 48 | 48 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.53e-06 | 71 | 48 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 8.90e-06 | 80 | 48 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | sensory perception of sound | 9.26e-05 | 9 | 48 | 2 | GO_0007605 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 2.68e-04 | 15 | 48 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 2.68e-04 | 15 | 48 | 2 | C0154017 | |
| Disease | triacylglycerol 52:3 measurement | 2.68e-04 | 15 | 48 | 2 | EFO_0010415 | |
| Disease | Carcinoma in situ of bladder | 2.68e-04 | 15 | 48 | 2 | C0154091 | |
| Disease | Carcinoma of bladder | 3.90e-04 | 18 | 48 | 2 | C0699885 | |
| Disease | hearing impairment | 5.51e-04 | 98 | 48 | 3 | C1384666 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 8.86e-04 | 27 | 48 | 2 | DOID:8552 (is_marker_for) | |
| Disease | triacylglycerol 50:4 measurement | 1.09e-03 | 30 | 48 | 2 | EFO_0010411 | |
| Disease | melanoma (is_marker_for) | 1.32e-03 | 33 | 48 | 2 | DOID:1909 (is_marker_for) | |
| Disease | refractive error, self reported educational attainment | 1.41e-03 | 34 | 48 | 2 | EFO_0004784, MONDO_0004892 | |
| Disease | phospholipid measurement | 1.55e-03 | 140 | 48 | 3 | EFO_0004639 | |
| Disease | Bladder Neoplasm | 1.55e-03 | 140 | 48 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.58e-03 | 141 | 48 | 3 | C0005684 | |
| Disease | cataract | 1.58e-03 | 141 | 48 | 3 | MONDO_0005129 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NDYHTPLDMAAMKGH | 96 | Q495M9 | |
| KHIHPHMNMDGDYIN | 266 | Q9HBW9 | |
| FMISADMAHAVHPNY | 351 | Q9ULA0 | |
| VVNAVYAMAHALHNM | 381 | Q14416 | |
| KMMQNHGHENITTYV | 301 | Q8TE57 | |
| KHNLYRDSMVMHNSD | 561 | Q96TA1 | |
| HHSAAESFMKYMQNE | 436 | P35228 | |
| PLHYSTIMNHHMCVA | 126 | Q8NGZ3 | |
| HYGQQMKLSMKHQLP | 256 | A0AUZ9 | |
| MAMYPHVTQADLKSS | 576 | Q8IXI2 | |
| SNVLSHSYCLHPDMM | 171 | Q9H344 | |
| MAMMTHLHEPAVLYN | 91 | Q9UKX2 | |
| KMSDPNMEANSHYGH | 651 | P16284 | |
| MAMMTHLHEPAVLYN | 91 | P12882 | |
| SMAYALHNMHKDLCP | 411 | O00222 | |
| HHYSLEMYQKMQSPH | 311 | Q9NXE4 | |
| LHAMNSLSAMYNLHQ | 11 | Q8NFW5 | |
| MSLHALYMHQLHKQQ | 706 | Q7Z3C6 | |
| HLASLYANNHPSMHM | 1121 | O75976 | |
| YGFNMVMSHPHAVNE | 236 | Q96PY5 | |
| EPTQYSMDHFSGMHN | 151 | Q16760 | |
| HRMDKPANCTHDLYM | 711 | P22607 | |
| ANLHSKASMTMPDVY | 51 | Q96CH1 | |
| LHNMSEAMAVTAYHQ | 336 | Q8TDX9 | |
| MAAVTQLQNSHMYAH | 501 | P35680 | |
| LNAHGAAQMQPMHRY | 186 | P48431 | |
| NTLFMAMEHYPMTEH | 591 | P35499 | |
| PYIMKTSQHFNDMSN | 1041 | O14827 | |
| HEKVYFHPMTNAATM | 131 | A6NEY8 | |
| AHSPQPNYIHDMNRM | 191 | Q8IV36 | |
| HGYAHQPALMHSESM | 1081 | Q9Y2K2 | |
| MSKMHSHPSASNNSY | 441 | Q6ZSJ9 | |
| MAMMTHLHEPAVLYN | 91 | Q9Y623 | |
| ICHPLQYHTMMSKTL | 126 | A6NMS3 | |
| HMVHKPDDDTDMYNT | 106 | O94875 | |
| IHHYNMSTSLNPMRK | 116 | Q5T5D7 | |
| GLYTMAHNPNMTHLK | 111 | Q9H900 | |
| DSFMSVYPMQTEHHQ | 1136 | Q8N3U4 | |
| YNSLSIAMQTLKHMP | 146 | Q13888 | |
| SVDLHTHCSYQMMLP | 346 | O95630 | |
| DASQSSMHNALHIYM | 356 | P14679 | |
| MAMMTHLHEPAVLYN | 91 | Q9UKX3 | |
| PHQKASLEHMASMQY | 501 | Q5HYM0 | |
| TFQYPSQLQNHMMKH | 401 | Q8N895 | |
| SNMKLHMKRAHSYAG | 1791 | Q9UL36 | |
| LTVHQTSHMEMKPYE | 256 | P17014 | |
| YPMQKRLTQHMKTHS | 571 | Q9H4Z2 | |
| GMKYHVMANHNSLPI | 211 | Q96ME7 | |
| LHSTPMKMAVHNLYS | 16 | Q8N228 |